Current Research into Tinnitus Medications
A 2005 review in Brazil utilizing acamprosate (Campral), a medicine employed to deal with alcoholism, resulted in an 87 Percent level of relief of tinnitus symptoms. Further research into this drug and its potential for tinnitus relief is continuing in the United States.
There are cases where tinnitus medications can reduce the irritation levels of patient symptoms or their associated complications, but there is nothing out yet that is a positive cure for tinnitus. Here are some currently used medications:
Tricyclic antidepressants, for example amitriptyline and nortriptyline, are already used with some success. Even so, these tinnitus medications are usually useful for only severe cases, as they can result in problematic adverse reactions, which include dry mouth, irregular bowel movements, coronary heart and blurred vision troubles.
Alprazolam (Niravam, Xanax) may help decrease tinnitus symptoms, but negative effects may incorporate tiredness and nausea or vomiting. It can also induce drug dependency.
Some Medications Actually Cause Tinnitus
What Causes Tinnitus
Tinnitus Medications – Current Research
Animal studies found that when the drug was put into the ears, it reduced the sounds of tinnitus. And in a small pilot study involving human volunteers in Germany, the majority of sufferers who were administered this drug reported a substantial decrease in tinnitus symptoms. However, once the treament was over, the problem returned to the same levels as before. A new 24 patient trial has commenced at the Avicenne Hospital in France.Since ongoing treatment appears necessary, scientists are looking at creating a entirely implanted medication pump. This has an internal reservoir that they can believe will administer the medication for over a calendar year, after which it can be refilled through the skin under a minor surgical operation.
Doctor Ralph Holme, director of Biomedical Research at the Royal National Institute for that Deaf, affirms:
‘In recent years, there has been research into a number of drugs which aim to reduce the hyperactivity in the brain associated with tinnitus. This particular study is interesting, as it is also testing a new way of administering a drug by pumping it straight into the inner ear.’
He added that the glutamate problem mentioned above, is showing up more frequently as being the probable culprit.
‘We know from animal studies that reducing levels of glutamate in the ear leads to a lessening of tinnitus. If it does work in humans, it would, therefore, address a cause, rather than existing treatments which tackle the symptoms. The approach may benefit people with relatively new cases of tinnitus, but we do not yet know whether it works in well-established tinnitus. If found to be safe, it could also lead to the development of new devices to inject these drugs directly into the ear.’